NeueHealth, Inc. (NEUE)
Oct 2, 2025 - NEUE was delisted (reason: taken private)
6.75
+0.08 (1.24%)
Inactive · Last trade price on Oct 1, 2025
NeueHealth Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -50.24 | -99.72 | -1,266 | -1,360 | -1,185 | -248.44 |
Depreciation & Amortization | 14.22 | 15.65 | 24.17 | 50.58 | 35.48 | 8.29 |
Stock-Based Compensation | 40.3 | 70.21 | 83.69 | 109.71 | 68.42 | 5.45 |
Other Adjustments | -32.78 | -61.49 | 574.76 | 274.07 | -85.63 | 2.67 |
Change in Receivables | 90.31 | 18.8 | -24.45 | -70.39 | -32.94 | 24.63 |
Changes in Accounts Payable | -2.04 | -3.94 | -149.33 | 2.7 | 192.61 | -3.96 |
Changes in Accrued Expenses | -65.83 | -69.57 | -2,288 | 1,292 | 1,218 | 179.57 |
Changes in Unearned Revenue | 0.09 | 0.08 | -10.61 | -42.76 | 14.9 | 18.62 |
Changes in Other Operating Activities | -63.98 | 6.76 | 329.39 | -21.83 | -143.46 | -44.06 |
Operating Cash Flow | -69.94 | -123.22 | -2,727 | 234.47 | 82.06 | -57.24 |
Operating Cash Flow Growth | - | - | - | 185.73% | - | - |
Capital Expenditures | -4.11 | -2.33 | -2.9 | -27.45 | -30.41 | -6.47 |
Purchases of Investments | -13.64 | -14.96 | -837.07 | -1,457 | -1,018 | -916.82 |
Proceeds from Sale of Investments | 8.88 | 7.07 | 1,960 | 1,055 | 926.9 | 463.89 |
Payments for Business Acquisitions | - | - | - | -0.31 | -431.79 | -230.33 |
Proceeds from Business Divestments | 61.14 | 197.12 | -0.68 | - | - | - |
Investing Cash Flow | 52.26 | 186.89 | 1,120 | -429.72 | -552.89 | -689.74 |
Short-Term Debt Issued | 2 | 2 | - | 303.95 | 355 | - |
Short-Term Debt Repaid | -1 | -273.64 | - | -155 | -200 | - |
Net Short-Term Debt Issued (Repaid) | 1 | -271.64 | - | 148.95 | 155 | - |
Long-Term Debt Issued | 67.39 | 119.8 | 66.4 | - | - | - |
Net Long-Term Debt Issued (Repaid) | 67.39 | 119.8 | 66.4 | - | - | - |
Issuance of Common Stock | - | - | - | 1.32 | 898.72 | 1.24 |
Net Common Stock Issued (Repurchased) | - | - | - | 1.32 | 898.72 | 1.24 |
Issuance of Preferred Stock | - | - | - | 920.42 | - | 711.2 |
Net Preferred Stock Issued (Repurchased) | - | - | - | 920.42 | - | 711.2 |
Other Financing Activities | -99.24 | -101.72 | -16.49 | -4.31 | -10.08 | - |
Financing Cash Flow | -30.85 | -253.55 | 49.91 | 1,066 | 1,044 | 712.44 |
Net Cash Flow | -48.53 | -189.88 | -1,557 | 871.11 | 572.81 | -34.54 |
Beginning Cash & Cash Equivalents | 261.46 | 375.28 | 1,932 | 1,061 | 488.37 | 522.91 |
Ending Cash & Cash Equivalents | 212.93 | 185.41 | 375.28 | 1,932 | 1,061 | 488.37 |
Free Cash Flow | -74.05 | -125.55 | -2,729 | 207.02 | 51.65 | -63.71 |
Free Cash Flow Growth | - | - | - | 300.85% | - | - |
FCF Margin | -8.34% | -13.42% | -235.15% | 25.67% | 3.41% | -12.37% |
Free Cash Flow Per Share | -8.70 | -15.26 | -343.15 | 26.31 | 10.53 | -37.42 |
Levered Free Cash Flow | -188.05 | -391.51 | -3,232 | -92.77 | 256.79 | -96.46 |
Unlevered Free Cash Flow | -155.11 | -164.64 | -2,673 | 937.18 | 969.09 | -9.24 |